2013 annual financial data
Regencell Bioscience 2013 Operating margin
Direct answer
Operating margin was 11.83%.
Operating income was 334,200,000 USD and net income was 144,800,000 USD.
Operating cash flow was 346,600,000 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,824,200,000 USD
- Operating income
- 334,200,000 USD
- Net income
- 144,800,000 USD
- Operating cash flow
- 346,600,000 USD